These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3220460)
1. Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice. van Buul-Offers S; Hoogerbrugge CM; Branger J; Feijlbrief M; Van den Brande JL Horm Res; 1988; 29(5-6):229-36. PubMed ID: 3220460 [TBL] [Abstract][Full Text] [Related]
2. Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. van Buul-Offers S; Ueda I; Van den Brande JL Pediatr Res; 1986 Sep; 20(9):825-7. PubMed ID: 3748655 [TBL] [Abstract][Full Text] [Related]
3. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. van Buul-Offers SC; Reijnen-Gresnigt MG; Hoogerbrugge CM; Bloemen RJ; Kuper CF; Van den Brande JL Endocrinology; 1994 Sep; 135(3):977-85. PubMed ID: 7520865 [TBL] [Abstract][Full Text] [Related]
4. Biosynthetic human growth hormone: effects on growth of Snell dwarf mice. van Buul-Offers S; Van den Brande JL Horm Metab Res; 1985 Jan; 17(1):20-4. PubMed ID: 3967843 [TBL] [Abstract][Full Text] [Related]
5. Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice. Van Buul-Offers SC; Van Kleffens M; Koster JG; Lindenbergh-Kortleve DJ; Gresnigt MG; Drop SL; Hoogerbrugge CM; Bloemen RJ; Koedam JA; Van Neck JW Endocrinology; 2000 Apr; 141(4):1493-9. PubMed ID: 10746655 [TBL] [Abstract][Full Text] [Related]
6. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Skottner A; Clark RG; Fryklund L; Robinson IC Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163 [TBL] [Abstract][Full Text] [Related]
7. Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV. Blum WF; Ranke MB; Bierich JR Acta Endocrinol (Copenh); 1986 Feb; 111(2):271-84. PubMed ID: 3953237 [TBL] [Abstract][Full Text] [Related]
8. Dexamethasone differentially inhibits thyroxine- or growth hormone-induced body and organ growth of Snell dwarf mice. Rooman RP; Kuijpers G; Gresnigt R; Bloemen R; Koster JG; van Buul-Offers SC Endocrinology; 2003 Jun; 144(6):2553-8. PubMed ID: 12746318 [TBL] [Abstract][Full Text] [Related]
9. Co-administration of IGF-binding protein-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice. van Buul-Offers S; Reijnen-Gresnigt R; Bloemen R; Hoogerbrugge C; Van den Brande JL Prog Growth Factor Res; 1995; 6(2-4):377-83. PubMed ID: 8817681 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice. Chatelain PG; Sanchez P; Saez JM Endocrinology; 1991 Apr; 128(4):1857-62. PubMed ID: 2004605 [TBL] [Abstract][Full Text] [Related]
11. The Snell-dwarfmouse. II. Sulphate and thymidine incorporation in costal cartilage and somatomedin levels before and during growth hormone and thyroxine therapy. van Buul S; Van den Brande JL Acta Endocrinol (Copenh); 1978 Dec; 89(4):646-58. PubMed ID: 716773 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids. Hynes MA; Van Wyk JJ; Brooks PJ; D'Ercole AJ; Jansen M; Lund PK Mol Endocrinol; 1987 Mar; 1(3):233-42. PubMed ID: 3453890 [TBL] [Abstract][Full Text] [Related]
13. Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters in hypopituitary dwarf mice. Holder AT; Spencer EM; Preece MA J Endocrinol; 1981 May; 89(2):275-82. PubMed ID: 7241014 [TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone, prolactin and thyroxine on body wegith, somatomedin-like activity and in-vivo sulphation of cartilage in hypopituitary dwarf mice. Holder AT; Wallis M; Biggs P; Preece MA J Endocrinol; 1980 Apr; 85(1):35-41. PubMed ID: 7391723 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I stimulates growth in normal growing rats. Hizuka N; Takano K; Shizume K; Asakawa K; Miyakawa M; Tanaka I; Horikawa R Eur J Pharmacol; 1986 Jun; 125(1):143-6. PubMed ID: 3732389 [TBL] [Abstract][Full Text] [Related]
16. Effects of Spirometra erinacei plerocercoids on the growth of Snell dwarf mice. Shiwaku K; Hirai K; Torii M; Tsuboi T Parasitology; 1983 Dec; 87 (Pt 3)():447-53. PubMed ID: 6657302 [TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of Snell dwarfmice. Van den Brande JL; van Buul-Offers S Acta Endocrinol (Copenh); 1979 Oct; 92(2):242-57. PubMed ID: 494990 [No Abstract] [Full Text] [Related]
18. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I. Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975 [TBL] [Abstract][Full Text] [Related]
19. Clinical use of somatomedin-1: yes or no? Laron Z Paediatr Drugs; 1999; 1(3):155-9. PubMed ID: 10937448 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity. Herington AC; Kuffer AD Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]